Disabled Americans Fear What Medicaid Cuts Could Do to Them
Her ileostomy bag needs to be emptied multiple times a day, and the exposed end of her intestine must be inspected. Her body has to be regularly repositioned in her wheelchair so that she won't get sores. Her saliva needs to be suctioned from her mouth to prevent aspiration, and her food and medication must be administered through a gastric tube.
June has rare diseases that affect her intestines and brain. Her parents do what they can for her, but they have jobs and two other children — they can't do it all. What allows June to live at home, go to school and hang out with friends is a Medicaid program in Utah that provides in-home nurses, a type of benefit called home- and community-based care.
That care means she doesn't have to live in a nursing home or other medical institution, said her mother, Courtney Demmitt-Rice.
'We would do anything to keep that from happening,' she said. 'But your body can only give so much.'
Medicaid is best known as a program for low-income people, but it is also a key vehicle by which disabled Americans of varying income levels receive health care that would otherwise be prohibitively expensive. June is one of about 4.5 million Americans who depend specifically on its home- and community-based care services, which often come through specialized programs known as waivers.
That 4.5 million includes many older Americans who are on Medicare too but can't get the home care they need through that. But it also includes many working-age adults, and about 14 percent of the total are 18 or younger, according to the health research group KFF.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
9 minutes ago
- Medscape
How Myeloma Plays Hide and Seek With CAR T Cells
TOPLINE: G protein-coupled receptor, class C, group 5, member D (GPRC5D) loss after chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM) occurs through biallelic genetic inactivation and hypermethylation-driven epigenetic silencing. Among 10 patients who relapsed, eight showed GPRC5D loss, while two had mixed expression. METHODOLOGY: Researchers conducted whole-genome sequencing (WGS) and whole-genome bisulfite sequencing (WGBS) analysis on MM samples from 10 patients who relapsed after GPRC5D CAR T-cell therapy. Analysis included CD138+ MM cells isolated from bone marrow samples with purity exceeding 80%, with tumor samples sequenced at 100× coverage and matched normal samples at 30× coverage. Investigators performed targeted bisulfite sequencing to evaluate methylation status of GPRC5D regulatory regions across seven MM cell lines, with library construction and sequencing conducted by specialized institutes. Patient characteristics included median age of 57.5 years (range, 44-66 years), equal gender distribution, and 90% having high-risk cytogenetic abnormalities. TAKEAWAY: Genetic alterations were identified in three cases: one with homozygous deletion in GPRC5D gene, another with biallelic loss in regulatory regions, and a third with homozygous deletions in both TNFRSF17 and GPRC5D after sequential anti-B-cell maturation antigen and anti-GPRC5D CAR T-cell therapies. Multiple hypermethylation sites were present in transcriptional regulatory elements of GPRC5D gene in five posttreatment MM samples, with no genetic changes detected at GPRC5D locus in seven cases. GPRC5D expression showed inverse correlation with methylation levels in regulatory regions of MM cell lines, with azacitidine treatment inducing GPRC5D messenger RNA and protein expression in hypermethylated MM cell lines. All 10 patients achieved complete response or better as best response with median time to best response of 2.5 months (range, 0.5-15.3 months), though median time to disease progression was 15.9 months (range, 3.0-26.5 months). IN PRACTICE: 'Our findings highlight that biallelic genetic inactivation and hypermethylation-driven epigenetic silencing are key mechanisms contributing to GPRC5D loss and treatment resistance,' wrote the authors of the study. SOURCE: The study was led by Mingshan Niu, Blood Diseases Institute, Xuzhou Medical University in Xuzhou, China. It was published online in Blood. LIMITATIONS: According to the authors, the structural variant deletions on chromosomes may be missed by 100× WGS in patients with a clone size less than 20%. The limit of detection for quantitative polymerase chain reaction ranged from 16 to 50 copies per reaction, indicating sensitivity limitations of these detection methods. Additionally, genetic alterations in the GPRC5D locus could either be acquired after CAR T-cell therapy or selected from preexisting clones, necessitating more sensitive detection methods for dynamic monitoring. DISCLOSURES: The research received support from the National Natural Science Foundation of China (82270181) and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (21KJA320005). The authors reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
26 minutes ago
- Yahoo
One new measles case in Utah, bringing total cases to 11
SALT LAKE CITY (ABC4) — The (DHHS) identified another measles case in Southern Utah, bringing the total number of cases to four in the region. There are now a total of 11 cases in the beehive state, . PREVIOUSLY: One new measles case in Utah, bringing total to 10 As of Tuesday, the majority of measles cases, that is seven of the 11 cases, have been identified in Utah County. Officials are encouraging the public to get vaccinated against measles, if they aren't already. At this time, no additional information has been released on the newest case. However, Utah DHHS has been updating public information each Wednesday. What is measles? Measles is a highly contagious virus that spreads easily through the air through coughing and sneezing. The CDC said those infected won't see symptoms appear until about a week after infection, and common symptoms include high fever, cough, and a rash. Myths VS Facts: What health officials want you to know about the MMR vaccine Tiny white spots may appear inside the mouth two to three days after symptoms begin. Measles can cause serious health complications, especially for those who are not protected through the measles, mumps, and rubella (MMR) vaccine. The measles rash appears 3 to 5 days after the first symptoms. It usually begins as flat red spots that appear on the face at the hairline. They then spread downward to the neck, trunk, arms, legs, and feet. Measles in Utah Utah has largely been in the last 10 years. There have only been five confirmed cases since 2015, including three in 2017. However, Utah has had an increase in cases in recent weeks after a passenger with measles . During the 2024/2025 school year, about 10% of in-person kindergarten students in Utah had an exemption for the MMR vaccine or were missing documentation to show they are vaccinated against measles, DHHS noted. Amelia Salmanson, the department's preventable disease manager, notes that the organization has been preparing for measles in Utah for at least a year and have been working to reduce measles transmission outside of the identified households. 'We've been working really closely with our local health departments and our clinical partners to develop plans and processes to ensure that the transmission of measles stays ideally within kind of that immediate group,' Salmanson said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Yahoo
42 minutes ago
- Yahoo
Trump's vein diagnosis gives rare glimpse into health issues
The White House's announcement that President Trump has a common chronic vein condition marked a rare glimpse into the health of the oldest person to be elected U.S. president, whose campaign and administration have long projected him as the picture of strength and vitality. Trump, 79, has chronic venous insufficiency, according to the White House physician. The condition occurs when a person's leg veins struggle to pump blood back to the heart, causing blood to pool. White House press secretary Karoline Leavitt made the disclosure at the top of a routine press briefing late last week, after images had been circulating online of Trump with swollen legs at the FIFA Club World Cup and a bruised hand covered in makeup. 'I know that many in the media have been speculating about bruising on the president's hand and also swelling in the president's legs. So, in the effort of transparency, the president wanted me to share a note from his physician with all of you today,' Leavitt said, before outlining Trump's condition. She said the bruising on his hands is 'consistent with minor-soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.' The White House later released a more detailed memo from the White House physician. Critics have accused Trump of trying to hide the true details of his health behind bluster, so the announcement of a specific diagnosis came with some surprise — and a certain amount of skepticism. Barbara Perry, a presidential historian and professor at the University of Virginia, called it 'a rather sudden turnaround from the Trump White House.' Perry commended the administration on its transparency but noted the public needs to believe what it's being told. 'Do we have complete information now? We don't know that. We only know what they have told us, and we have to presume that it is accurate,' Perry said. It's not unusual for an administration to be reticent about sharing a president's personal health information, and there's no legal requirement for an administration to be transparent about it. Perry noted there's a tension between what a president wants to disclose and what the American people have a vested interest in knowing. There's no incentive for anyone in the administration — let alone the White House physicians — to be truthful and transparent about the person who could fire them. Perry said she would put Trump toward the same end of the transparency spectrum as former President Biden, who dropped out of the race last summer after a debate performance where he appeared unfocused, confused and unable to respond to many of Trump's attacks. Biden's White House denied reports of any mental decline. But by the end of his term, the public had lost confidence in his ability to lead. Trump during the campaign often boasted of his physical health and stamina as he sought to draw a contrast with Biden. While in office, he has continued to accuse Biden and his aides of covering up the alleged mental decline, and Trump's GOP allies in Congress have launched an investigation into what those White House aides knew. Yet Trump has hardly been forthcoming himself. When he was infected with COVID-19 in fall 2020, the administration did not release many details about his condition or treatment. His physician Sean Conley repeatedly downplayed the seriousness of the illness. It wasn't until months later — after the publication of a book from former chief of staff Mark Meadows and investigation by The New York Times — that the public learned just how seriously ill the president was. The Times reported Trump's blood oxygen was so low before he was admitted to Walter Reed National Military Medical Center that officials believed he would need to be put on a ventilator. He recovered after being granted special access to an unapproved drug to fight the virus. Trump during the campaign pledged to release his medical records but then did not share even basic health data. Like much of Trump's medical history, the information that has been released has been largely hyperbolic. In 2015, Trump released a letter from his then-physician Harold Bornstein that said he would be the healthiest president in history. Two years later, Bornstein admitted Trump dictated the letter himself. During his first term in 2018, Trump's former White House doctor Ronny Jackson, now an ally in Congress, said the president had 'incredibly good genes' and joked that he might live to 200 years old if he had a healthier diet. Current White House physician Sean Barbabella wrote in a memo after Trump's annual physical in April that the president lives an active lifestyle that includes 'frequent victories in golf events.' Barbabella pronounced Trump 'fully fit' to execute the duties of the presidency. Trump will be 82 at the end of his term, which would make him the oldest person to hold the office, beating Biden's mark by just a few months. Even after he was grazed by a would-be assassin's bullet in July 2024, the Trump campaign provided very little information about his recovery or any lingering health effects. Jeffrey Kuhlman, who served as former President Obama's physician from 2009-13 and ran the White House Medical Unit for former President George W. Bush, said he thinks the current administration realized Trump's physical condition couldn't be hidden. 'It's at least a breath of fresh air' to see transparency about 'conditions the rest of us could see already,' Kuhlman said. 'Presidents don't like to talk about their health unless they are forced to. When you have bruises on your hands and swollen ankles … you don't get brownie points for this.' Kuhlman, who wrote a 2024 book about his experiences as a White House doctor, said he was heartened to see a memo from Trump's White House physician that was 'competent and factual.' 'I'm not sure it's a turning point in transparency, but it is promising to at least see a doctor write something factual, and have a competent workup,' Kuhlman said. 'This is the first [memo] that's been written by a doctor instead of by Trump himself.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
